Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TREC
NCT01165112Phase 2Completed
- Sponsor
- University of Washington
- Start
- Sep 2010
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bendamustine in diffuse large B-cell lymphoma (DLBCL) and Hodgkin lymphoma (HL), sponsored by University of Washington. Primary endpoints: Maximally Tolerated Dose and Safety and Toxicity. Started Sep 2010; status: completed.
02
Drugs
bendamustine
03
Conditions
diffuse large B-cell lymphoma (DLBCL)Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT01165112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01165112.